Company: HCTI
Filing Date: 2025-11-25
Form Type: 424B3
Source: 0001213900-25-114840
Chunk: 1

Company: Healthcare Triangle, Inc.
Filing Date: 2025-11-25
Form: 424B3
Chunk 1
---
, to fulfill our contractual obligations to provide for the
registration of the resale of the Resale Shares by Selling Stockholders. See “Warrant Inducement Private Placement” and “Selling
Stockholders” beginning on pages 13, and 15 of this prospectus for more information about the Inducement Warrants,
and the Selling Stockholders. The registration of the shares of Common Stock to which this prospectus relates does not require the Selling
Stockholders to sell any of their shares of our Common Stock.

We are not offering any shares
of Common Stock under this prospectus and will not receive any proceeds from the sale or other disposition of the shares of our Common
Stock covered hereby. However, we will receive the proceeds from any exercise of the Common Warrants for cash. See “Use of Proceeds”
beginning on page 14 of this prospectus.

The Selling Stockholders
identified in this prospectus, or their pledgees, assignees, donees, transferees or their respective successors-in-interest, from time
to time may offer and sell through public or private transactions at prevailing market prices, at prices related to prevailing market
prices or at privately negotiated prices the shares held by them directly or through underwriters, agents or broker-dealers on terms
to be determined at the time of sale, as described in more detail in this prospectus. See “Plan of Distribution” beginning
on page 18 of this prospectus for more information about how the Selling Stockholders may sell their respective shares of Common
Stock. The Selling Stockholders may be deemed “underwriters” within the meaning of Section 2(a)(11) of the Securities Act
of 1933, as amended. (the “Securities Act”).

We have agreed, pursuant
to the terms of the Inducement Agreement, and the Advisory Agreement, as applicable, to bear all of the expenses in connection with the
registration of the Resale Shares pursuant to this prospectus. The Selling Stockholders will pay or assume all commissions, discounts,
fees of underwriters, agents, selling brokers or dealer managers and similar expenses, if any, attributable to their respective sales
of the shares of Common Stock.

Our Common Stock is listed
on the Nasdaq Capital Market under the symbol “HCTI”. On November 18, 2025, the closing price of our Common Stock on the
Nasdaq Capital Market was $2.10 per share.

This offering will terminate on the earlier of